Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures.
Cooper HA, Jones CP, Campion E, Roberts HR, Hedner U
Haemophilia 2001;7(5):517-522.
Review by M. Aldouri
Recombinant activated factor VII for adjunctive hemorrhage control in trauma – Discussion.
Holcomb J, Mattox KL, Schreiber MA, Martinowitz U
J Trauma 2001;51(3):438-439.
Review by M. Aldouri